Novavax Inc (NVAX)
3.955
-0.20
(-4.70%)
USD |
NASDAQ |
Apr 25, 12:35
Novavax Cash from Investing (Quarterly): -9.078M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -9.078M |
| September 30, 2023 | -18.39M |
| June 30, 2023 | -7.779M |
| March 31, 2023 | -23.56M |
| December 31, 2022 | -22.06M |
| September 30, 2022 | -29.52M |
| June 30, 2022 | -24.58M |
| March 31, 2022 | -16.83M |
| December 31, 2021 | -16.36M |
| September 30, 2021 | -12.19M |
| June 30, 2021 | -12.90M |
| March 31, 2021 | 141.61M |
| December 31, 2020 | -31.12M |
| September 30, 2020 | -100.71M |
| June 30, 2020 | -188.22M |
| March 31, 2020 | -57.73M |
| December 31, 2019 | -0.216M |
| September 30, 2019 | 17.97M |
| June 30, 2019 | 2.024M |
| March 31, 2019 | 18.71M |
| December 31, 2018 | 48.32M |
| September 30, 2018 | 7.996M |
| June 30, 2018 | -48.30M |
| March 31, 2018 | 20.59M |
| December 31, 2017 | 16.76M |
| Date | Value |
|---|---|
| September 30, 2017 | 41.96M |
| June 30, 2017 | 2.531M |
| March 31, 2017 | -25.28M |
| December 31, 2016 | 85.90M |
| September 30, 2016 | 92.57M |
| June 30, 2016 | 18.98M |
| March 31, 2016 | -169.44M |
| December 31, 2015 | 9.559M |
| September 30, 2015 | -9.21M |
| June 30, 2015 | -39.41M |
| March 31, 2015 | 17.79M |
| December 31, 2014 | 17.35M |
| September 30, 2014 | -54.10M |
| June 30, 2014 | -102.78M |
| March 31, 2014 | 9.701M |
| December 31, 2013 | 9.161M |
| September 30, 2013 | 15.41M |
| June 30, 2013 | -3.207M |
| March 31, 2013 | -4.974M |
| December 31, 2012 | -17.12M |
| September 30, 2012 | -7.349M |
| June 30, 2012 | -4.528M |
| March 31, 2012 | -3.27M |
| December 31, 2011 | 0.804M |
| September 30, 2011 | 3.624M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-188.22M
Minimum
Jun 2020
141.61M
Maximum
Mar 2021
-21.56M
Average
-16.83M
Median
Mar 2022
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc | -11.00B |
| Moderna Inc | -538.00M |
| Agilent Technologies Inc | -95.00M |
| Lexicon Pharmaceuticals Inc | 51.90M |
| Vaxart Inc | 15.10M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -176.78M |
| Cash from Financing (Quarterly) | 100.39M |
| Free Cash Flow | -772.77M |
| Free Cash Flow Per Share (Quarterly) | -1.500 |
| Free Cash Flow to Equity (Quarterly) | -186.25M |
| Free Cash Flow to Firm (Quarterly) | -181.70M |
| Free Cash Flow Yield | -187.2% |